Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.

Oncotarget · 2016 · PMC4951328 · PMID 26959748

Europe PMC DOI

hedged sentence

0.1600

closest p · 3.2× alpha

0.1600

boldest claim

The sentences

showed a trendP = 0.16not close (p > 0.1)

Among the conventionally high-risk patients as defined by age, stage, histology, and MYCN status ( n = 30) [ 23 , 24 ], PET-UHR ( n = 22) showed a trend of worse 5-year EFS (12% [2%–31%] vs . 38% [6%–72%]; P = 0.16) and OS (24% [6%–47%] vs . 50% [1%–91%]; P = 0.07).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.